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Early Cerebral Perfusion Pressure Augmentation With Phenylephrine After
Traumatic Brain Injury May Be Neuroprotective in a Pediatric Swine Model
Abstract
Objective: Cerebral perfusion pressureage, and current guidelines recommend maintaining cerebral
perfusion pressure between 40 mm Hg–60 mm Hg. Although adult traumatic brain injury studies have
observed an increased risk of complications associated with targeting a cerebral perfusion pressure >70,
we hypothesize that targeting a cerebral perfusion pressure of 70 mm Hg with the use of phenylephrine
early after injury in the immature brain will be neuroprotective.
Design: Animals were randomly assigned to injury with a cerebral perfusion pressure of 70 mm Hg or 40
mm Hg. Diffuse traumatic brain injury was produced by a single rapid rotation of the head in the axial
plane. Cerebral microdialysis, brain tissue oxygen, intracranial pressure, and cerebral blood flow were
measured 30 min–6 hrs postinjury. One hour after injury, cerebral perfusion pressure was manipulated
with the vasoconstrictor phenylephrine. Animals were euthanized 6 hrs posttraumatic brain injury, brains
fixed, and stained to assess regions of cell injury and axonal dysfunction.
Setting: University center.
Subject: Twenty-one 4-wk-old female swine.
Measurements and Main Results: Augmentation of cerebral perfusion pressure to 70 mm Hg resulted in
no change in axonal dysfunction, but significantly smaller cell injury volumes at 6 hrs postinjury compared
to cerebral perfusion pressure 40 (1.1% vs. 7.4%, p < .05). Microdialysis lactate/pyruvate ratios were
improved at cerebral perfusion pressure 70 compared to cerebral perfusion pressure 40. Cerebral blood
flow was higher in the cerebral perfusion pressure 70 group but did not reach statistical significance.
Phenylephrine was well tolerated and there were no observed increases in serum lactate or intracranial
pressure in either group.
Conclusions: Targeting a cerebral perfusion pressure of 70 mm Hg resulted in a greater reduction in
metabolic crisis and cell injury volumes compared to a cerebral perfusion pressure of 40 mm Hg in an
immature swine model. Early aggressive cerebral perfusion pressure augmentation to a cerebral
perfusion pressure of 70 mm Hg in pediatric traumatic brain injury before severe intracranial hypertension
has the potential to be neuroprotective, and further investigations are needed.
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Abstract
Objective—Cerebral perfusion pressure (CPP) less than 40 mm Hg following pediatric traumatic
brain injury (TBI) has been associated with increased mortality independent of age, and current
guidelines recommend maintaining CPP between 40–60 mm Hg. Although adult TBI studies have
observed an increased risk of complications associated with targeting a CPP > 70, we hypothesize
that targeting a CPP of 70 mm Hg with the use of phenylephrine early after injury in the immature
brain will be neuroprotective.
Design—Animals were randomly assigned to injury with CPP = 70 mm Hg (CPP70) or CPP =
40 mm Hg (CPP40). Diffuse TBI was produced by a single rapid rotation of the head in the axial
plane. Cerebral microdialysis, brain tissue oxygen, intracranial pressure, and cerebral blood flow
(CBF) were measured 30 min – 6 h post-injury. One hour after injury, CPP was manipulated with
the vasoconstrictor phenylephrine. Animals were euthanized 6 h post-TBI, brains fixed, and
stained to assess regions of cell injury and axonal dysfunction.
Setting—University center.
Subject—21 four week-old female swine.
Measurements and Main Results—Augmentation of CPP to 70 mm Hg resulted in no
change in axonal dysfunction, but significantly smaller cell injury volumes at 6 hours post injury
compared to CPP40 (1.1% vs. 7.4%, p < 0.05). Microdialysis lactate/pyruvate ratios were
improved at CPP70 compared to CPP40. CBF was higher in the CPP70 group but did not reach
statistical significance. Phenylephrine was well tolerated and there were no observed increases in
serum lactate or intracranial pressure in either group.
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Conclusions—Targeting a CPP of 70 mm Hg resulted in a greater reduction in metabolic crisis
and cell injury volumes compared to a CPP of 40 mm Hg in an immature swine model. Early
aggressive CPP augmentation to a CPP of 70 mm Hg in pediatric TBI before severe intracranial
hypertension has the potential to be neuroprotective, and further investigations are needed.
Keywords
pediatric head injury; cerebral perfusion pressure; phenylephrine; neuroprotection; swine; cerebral
blood flow

INTRODUCTION
Early post-traumatic brain injury (TBI) cerebral hypoperfusion may greatly contribute to
secondary brain injury, and therefore morbidity and mortality (1). Low cerebral blood flow
(CBF) states have been demonstrated in children by xenon CT scans following TBI within
24 hours of the initial injury, but by 48 hours these patients had normal or supernormal
blood flows (1). More recently, a retrospective study of children with severe TBI observed
that poorer outcomes were correlated with early low CBF (2). A retrospective study of 146
pediatric TBI patients observed a strong association of poor outcome at discharge with
hypotension within the first 6 hours of injury (3). The window for treatment of
hypoperfusion appears to be early after pediatric TBI, and may be of relatively short
duration in children.
Currently, pediatric cerebral perfusion pressure (CPP) thresholds used in the ICU
environment (40–60 mmHg) have been extrapolated from adult experimental and clinical
TBI and stroke studies (4–5). Chambers et al., have published much needed age-specific
pediatric thresholds for critical CPP, below which cerebral ischemia occurs with unfavorable
neurologic outcomes and increased mortality (6–8). These studies identified inadequate CPP
levels but did not identify an “optimal treatment” CPP, and therefore assumed that these
CPP levels were equivalent to brain injury insult thresholds. Use of currently accepted
pediatric CPP guidelines (CPP > 40 mm Hg) does not ensure adequate oxygen delivery to
brain tissue (9–10). This raises the question: is a CPP > 40 mm Hg in the pediatric TBI
patient high enough, and should this target CPP be modulated over time with a higher CPP
set early after injury? Mild induced hypertension after ischemic stroke has shown promise in
animal models but remains controversial in the clinical setting (11–12). Adult TBI studies
have observed an increased risk of adult respiratory distress syndrome associated with
targeting a CPP > 70 mm Hg, but it is unclear how applicable this is to the early
resuscitation of the head-injured child (13–14).
Initial stabilization of the pediatric TBI patient may occur in limited resource environments
where complex invasive intracranial monitoring may not be available. Early stabilization of
cerebrovascular hemodynamics with a vasopressor, such as phenylephrine, and targeting a
higher mean arterial pressure (MAP) or CPP may reduce brain injury and improve long-term
outcomes. We have previously developed a novel critical care model of pediatric closed
head injury that utilizes a large animal model to enable full clinical modalities used in neurointensive care (15). In this study, we tested the hypothesis that targeting a higher CPP (70 vs.
40 mm Hg) with the use of phenylephrine early after TBI in our immature swine model
would be neuroprotective.
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MATERIAL AND METHODS
Animal Preparation
All protocols were approved by the Institutional Animal Care and Use Committee of the
University of Pennsylvania. Four week-old female piglets whose brain development,
myelination, and cerebrovascular responses correspond to the human toddler were studied
(16–17). Piglets were anesthetized with an intramuscular injection of ketamine (20mg/kg)
and xylazine (2 mg/kg) followed by inhaled 4% isoflurane. Vitals signs including heart rate,
blood pressure, respiratory rate, end-tidal CO2, pulse oximetry, and rectal temperature were
monitored continuously and recorded every 15 minutes. Rectal temperature was maintained
between 37.5 – 38.5 °C using a heating pad.
Piglets were orally intubated and mechanically ventilated (positive end expiratory pressure
of 5 mm Hg, tidal volume 10–12 mL/kg). Femoral artery and venous catheters were placed
for continuous MAP monitoring, arterial blood gas sampling, and intravenous (IV) fluid
administration. Animals were administered 50 mcg/kg fentanyl IV, followed by a fentanyl
infusion (50 mcg/kg/hr) and normal saline (4 mL/kg/hr) (18). Following initiation of the
fentanyl infusion, isoflurane was reduced to 0.5–1%. Mechanical ventilation was adjusted to
maintain end-tidal CO2 between 35–40 mm Hg and fraction of inspired oxygen was
maintained between 28–30%. Pre- and post-injury arterial blood gas samples were obtained
hourly (Nova Biomedical, Waltham, MA) until euthanasia 6 hours after injury.
Non-impact rotational brain injury
Animals were randomized to either a goal CPP of 70 mm Hg (CPP70, N = 10), or 40 mm
Hg (CPP40, N = 11). Animals experienced rapid axial head rotations without impact (angle
rotation 90° over 10–12 msec) as described previously (19–21). Immediately prior to injury,
isoflurane was discontinued. Angular velocity was measured using an angular rate sensor
(ATA, Albuquerque, NM) attached to the linkage sidearm. After injury, mechanical
ventilation was continued and latency to return of pinch reflex following injury was
recorded and isoflurane 0.5–1% was resumed. The animal was removed from the bite-plate
and placed in the prone position.
Neuromonitoring
After injury, four burr holes were prepared for placement of fiber-optic intracranial pressure
monitor, brain tissue oxygen monitor, and microdialysis probe. The fiber-optic intracranial
pressure probe (Integra, Plainsboro, NJ), was secured with a single lumen bolt. The Licox
catheter system (Integra, Plainsboro, NJ) was placed to measure brain tissue oxygenation
(PbtO2). The brain tissue oxygen probe was inserted to a depth of 1.5 cm, secured with bone
wax, and allowed to equilibrate for 30 minutes before values were recorded. A hyperoxia
test was performed to confirm proper catheter placement. Data for intracranial pressure and
PbtO2 were recorded every 15 minutes until sacrifice.
A microdialysis probe (PAS 12, 4mm length, CMA, North Chelmsford, MA) was placed on
the opposite side of the skull from the PbtO2 catheter into subcortical white matter.
Immediately after insertion, the probe was infused with sterile 0.9% NaCl at a rate of 1 µL/
min. Dialysate samples were collected every 30 minutes until sacrifice and stored at −80 C
and analyzed for lactate and pyruvate using a CMA600 analyzer (CMA, North Chelmsford,
MA).
A CBF thermal diffusion probe (Hemedex, Cambridge, MA) was inserted to a depth of 1.5
cm in half of the animals in each group (CPP70 N = 5, CPP40 N = 6) and data was recorded
every 15 minutes until sacrifice. A separate group of injured animals (INJ, N=5) and
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instrumented shams (SHAM, N=4) underwent CBF monitoring as reference groups for CBF
values without CPP modulation.
Cerebral Perfusion Modulation
There is limited data on the comparative effectiveness of commonly used vasopressors in
adult and pediatric TBI. Phenylephrine has been reported to be the most commonly used
vasopressor for CPP modulation after TBI in both adult and pediatric retrospective studies
and was chosen for these studies (22–23). Due to the lack of data supporting or refuting
targeting a CPP of 70 mm Hg in children or immature animals early after TBI, we designed
our study to compare the accepted limits of the therapeutic range (40 mm Hg – 70 mm Hg).
One hour after injury, phenylephrine infusions were initiated and titrated to goal CPP (either
40 or 70 mm Hg) until euthanasia 6 hours after injury.
Histology
At 6 hours post-injury, animals were sacrificed via an overdose of pentobarbital. Brains
were perfusion-fixed, and two 6 µm sections were cut from every 3 mm block. Sections
were stained with Hematoxylin and Eosin (H&E), or with the immunohistochemical
markers for axonal injury beta-amyloid precursor protein (β-APP) (Chemicron 22C11 used
at dilution of 1:5000) and counterstained with Meyer's hematoxylin. Areas of cell injury on
H&E staining were identified by changes in staining intensity, and characterized by cell
shrinkage and cytoplasmic eosinophilia (24). Regions of β–APP reactivity and cell injury
were noted by a blinded neuropathologist and the locations of white matter damage and cell
injury were traced in each slice using our previously described procedure to determine total
area (15). Total and injured areas were multiplied by section thickness to determine total and
injured brain volumes.
Statistical Analysis
Physiological, arterial blood gas, and neuromonitoring parameter (ICP, PbtO2,
microdialysis, CBF) data were analyzed across groups, and time using repeated measures
ANOVA tests and Tukey-Kramer tests were used for post hoc analysis with significance
definied as P < 0.05. Six hour values for LPR and PbtO2 were compared to previously
reported historical controls for injured and sham animals with ANOVA tests. Dunnett’s tests
were employed to determine statistical significance of physiological data and intracranial
monitoring values pre-and post-administration of phenylephrine. Neuropathology
comparisons between groups were analyzed using Student’s t-test. All values are expressed
as mean ± the standard error of the mean. A post-hoc power analysis was performed. Based
on our previous results in injured animals, to detect a 3% difference in injury volumes with
80% power, a total of 20 animals (10 in each group) would be required (15).

RESULTS
Injury and Physiological Data
Angular peak velocity was similar between the two groups (CPP70, 171.7 ± 3.3 rad/s vs.
CPP40 170.2 ± 2.1 rad/s, p = 0.77). Average unconscious time (return of pinch reflex) was
also similar between the two groups (CPP70, 15.4 ± 2.5 min vs. CPP40 15.7 ± 1.9 min, p =
0.81). Physiological and arterial blood gas data for CPP40 and CPP70 are shown in Table 1
and 2 respectively. MAP was significantly higher in CPP70 after initiation of phenylephrine
one hour after injury, but there were no observed increases in arterial lactate levels due to
phenylephrine administration (Table 2). Of note, we observed a baseline metabolic alkalosis
in our animals (consistent with previous reports) and adjusted our goal PaCO2 to 40–45 mm
Hg (25). Phenylephrine dosing requirements for CPP70 were significantly higher compared
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to CPP40 (Table 3), but no significant changes in ICP were noted in either group after the
initiation of phenylephrine (Figure 1). CPP was significantly higher for CPP70 compared to
CPP40, and goal CPP was achieved and maintained in both groups (Figure 2).
Intracranial Monitoring
In order to assess temporal responses to CPP modulation, we measured PbtO2,
microdialysate lactate pyruvate ratios (LPR) as a measure of cellular metabolism, and CBF.
PbtO2 was higher for CPP70 compared to CPP40 after the initiation of phenylephrine but
did not reach statistical significance (Figure 3). PbtO2 responded to CPP modulation and
was significantly higher during the post-injury interval of 2–6 hours compared to initial
values measured within 1 hour of injury in CPP70, and during the post-injury interval of
3.5–5 hours in CPP40 (Figure 3).
After initiation of phenylephrine, CPP70 had significantly lower LPR compared to CPP40 p
< 0.05 (Figure 4). CPP modulation to 70 mm Hg resulted in significantly lower LPR levels
during the post-injury interval 2–6 hours compared to initial values measured within 1 hour
of injury. There was no correlation between serum and microdialysate lactate levels.
Repeated measures ANOVA analysis of CBF revealed significant group, time, and
group*time effects (Figure 5) (p < 0.05). Subsequent Tukey-Kramer analysis demonstrated
CBF for CPP70 was significantly higher compared to INJ (p < 0.05). CPP40 CBF was lower
than CPP70 after phenylephrine initiation but did not reach statistical significance.
Dunnett’s test for CPP70 demonstrated significantly higher CBF during the post-injury
interval 1.5–6 hours compared to initial post-injury values. Similarly, CP40 CBF was higher
during post-injury interval 3–5 hours compared to initial post-injury values.
Neuropathology
Neuropathology revealed regions of injury predominantly in the frontal and parietal lobes.
Traumatic axonal injury volumes at 6 hours post injury as determined by β-APP
immunohistochemistry were not different between the 2 groups (Figure 6). Cell injury
volumes determined by H&E were significantly larger in CPP40 compared to CPP70
(Figure 6). Regions of cell injury were predominantly observed in cortical regions of the
frontal lobes.

DISCUSSION
In the present study, the objective was to use our previously described clinically relevant
large animal model of pediatric neurocritical care to evaluate early CPP augmentation with
phenylephrine following non-impact inertial head injury (15). Our immature swine model
has the advantage of similar brain structure and development as the pediatric brain, and the
brain size can accommodate neuromonitoring equipment utilized in the pediatric intensive
care unit. Since there is currently no data supporting or refuting utilizing a CPP of 70 mm
Hg in children or immature animals early after TBI, we chose to compare the accepted limits
of the therapeutic range (40 mm Hg – 70 mm Hg).
Physiologic effects of phenylephrine
Phenylephrine infusions were successfully titrated to reach goal CPP. The larger dosing of
phenylephrine required to achieve the higher CPP was well tolerated without signs of
systemic tissue hypoperfusion (arterial lactate levels, Table 2), although animals were only
exposed to phenylephrine for 5 hours. Heart rates of animals in both groups gradually
increased over the 6 hour observation period, which we believe is due to the known
tachycardia associated with fentanyl infusions in immature swine and not attributable to
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phenylephrine (26). Previous studies in adult swine reported worsening pulmonary edema
with phenylephrine administration for CPP support (27), but we did not observe any changes
in PaO2 or FiO2 requirements. Peak MAPs achieved in the CPP70 group were within the
normal range of awake immature swine (25). Phenylephrine requirements to maintain goal
CPP were higher than typically observed in children but lower than reported in adult swine
models of TBI and hemorrhagic shock (28–29). These differences may be due to our use of
volatile anesthetics, the age of the animals, and/or variations in pharmacodynamics of
phenylephrine across species.
Early phenylephrine titration to higher CPP reduces cell injury
Our model tests whether early relative hypoperfusion contributes to the severity of
secondary brain injury before significant intracranial hypertension is observed. In our model,
animals had only mild intracranial hypertension in the early hours after injury; however we
observed significant areas of cell injury on H&E examination. Manipulation of CPP from 40
to 70 mm Hg resulted in significantly lower cell injury volumes, but there were no
differences in traumatic axonal injury volumes as assessed by β-APP
immunohistochemistry. We hypothesize that these areas of cell injury we observed and
reported previously result from decreased perfusion and metabolic crisis in specific cortical
regions (15), correlating well with the regions affected in children with TBI undergoing long
term follow-up (30).
CPP augmentation with phenylephrine improves PbtO2 following non-impact inertial head
injury
Phenylephrine infusions significantly improved PbtO2 in both groups. There are several
possible explanations for the lack of significant difference between the two groups. PbtO2 is
a small regional measurement, and in our model, probes were inserted to a depth of 1.5 cm
into the subcortical white matter of the frontal lobe. In these regions we observed no
difference in axonal injury by β-APP immunohistochemistry between groups. However,
differences in injury volumes between the groups were observed on H&E examination in
regions closer to the brain surface away from the region of PbtO2 detection in our model.
Increased PbtO2 in regions of injury may represent an improvement in oxygen delivery,
lower oxygen utilization due to altered cellular metabolism, or a combination of both. The
fidelity of PbtO2 monitoring is probably insufficient to be used as a single marker to detect
or describe all the effects of early CPP modulation on the reduction of secondary brain
injury.
CPP augmentation to 70 mm Hg early after injury improves brain cellular metabolism
Cellular metabolism as measured by cerebral microdialysis LPR was significantly improved
in CPP70 compared to CPP40. This would suggest an increase in substrate delivery with
aggressive CPP augmentation. Microdialysis sampling can create concentration gradients
which extends the region of brain tissue being measured several millimeters out from the
probe site (31). This is much further than PbtO2, which may explain the lack of statistical
significance of our PbtO2 measurements between the two groups. Our findings of
improvement in LPR with CPP augmentation are contrary to findings observed in the
pericontunsional tissue of adult head injured patients (32), but the pathophysiology and
response to rises in mean arterial pressure may differ in a non-impact diffuse injury model.
Phenylephrine improves CBF following non-impact head injury
Previous TBI studies in swine and humans have demonstrated improvement in PbtO2 after
CPP augmentation but have not directly measured CBF (29, 33). Utilizing a thermal
diffusion probe placed in the subcortical white matter, we were able to record repeated
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measurements of quantitative CBF over time. Along with improvement in PbtO2 and
cellular metabolism, we observed significant increases in quantitative CBF. These increases
in CBF were not associated with increases in ICP, which has been previously reported in a
rat model (34). Targeting a CPP of 70 mm Hg resulted in higher CBF with values
approaching CBF levels in anesthetized uninjured animals. It should be noted that the
observed average PaCO2 was slightly higher than current recommended guidelines, which
may alter CBF, although there were no statistical differences in PaCO2 between the groups.
We conclude CPP augmentation with phenylephrine early after TBI in an immature swine
model increases CBF, correcting hypoperfusion, reducing cellular metabolic crisis,
improving PbtO2, and results in a reduction in cell injury volumes.
Limitations of the study
There are several limitations to our experimental design which must be considered when
translating our results to the care of the pediatric patient with TBI. First, our model of nonimpact inertial head injury does not encompass the complete heterogeneity of pediatric TBI,
specifically focal contusions. The pathophysiology and responses to CPP augmentation in
uninjured, peri-contusional, and “core” contusion brain tissue may differ to what we have
observed in our diffuse injury model. Second, the effects of volatile anesthetics on cerebral
autoregulation and neuroprotection are well described, and may influence phenylephrine’s
effects on CBF and cell injury volumes (35–36). We are currently developing an anesthetic
plan for our model which avoids inhaled anesthetics and mimics sedation typically utilized
in the pediatric intensive care unit. Third, although we did not observe changes in arterial
oxygenation, ICP, or serum lactate with phenylephrine administration, brain and lung water
content were not measured. Increases in lung water content after phenylephrine
administration for CPP augmentation have been reported in adult swine (27). It is unclear if
immature swine have different phenylephrine pharmacodynamics and toxicity tolerances.
Fourth, the observation period was only a total of 6 hours after injury, limiting our outcome
measures to multi-modal intracranial monitoring and acute neuropathology and lacking
neurobehavioral functional outcomes. In future studies we plan to develop longer survival
times and apply our previously developed neurobehavioral outcome measures (19, 37).
Pediatric TBI patients may need vasopressor support for several days after injury, and it is
still unclear whether CPP augmentation with vasopressors and target CPP should change as
the injury evolves over time. Fifth, we chose a relatively short delay in administration of
phenylephrine after injury, and further investigations are needed to examine the length of the
therapeutic window. Sixth, we only utilized female swine in our study. Sex-dependent
differences in the response of CBF autoregulation to phenylephrine administration after TBI
have been reported in swine, and our results may not be generalizable to male swine (38–
39). Future studies to examine the role of sex in our non-impact head injury model are
planned. Seventh, there are a multitude of approaches to the augmentation of CPP; including
different vasopressors, colloid and crystalloid administration, and hyperosmolar therapy. We
chose phenylephrine since it is a commonly used vasopressor in pediatric TBI (23). Future
studies will evaluate other means of CPP augmentation. Finally, we chose to study only two
target CPP levels, a CPP of 40 and 70 mm Hg which are at or beyond the extremes of
current guideline recommendations (40). It is possible that a CPP between these two groups
may effectively reduce metabolic crisis, improve CBF, and reduce cell injury, with less risk
of systemic side effects.

CONCLUSION
In our swine model of pediatric closed head injury we observe early derangements in CBF,
PbtO2, cellular metabolism, and acute neuropathology. Early administration of
phenylephrine improved cerebral metabolism, CBF and PbtO2. Targeting a CPP of 70 mm
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Hg resulted in a greater reduction in metabolic crisis and cell injury volumes compared to a
CPP of 40 mm Hg, but did not result in statistically significant differences in CBF and
PbtO2 in a swine model of pediatric TBI. Early aggressive CPP augmentation to a CPP of 70
mm Hg in pediatric TBI before severe intracranial hypertension may be neuroprotective, and
further investigations are needed.
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Figure 1.

Intracranial pressure over time. Phenylephrine was initiated at 1 hour post injury.
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Figure 2.

Cerebral pressure over time. Phenylephrine was initiated at 1 hour post injury. (*P < 0.05).
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Figure 3.

Brain tissue oxygenation (PbtO2) over time. (* P < 0.05 for overall group means). INJ,
injured animals without phenylephrine support; Sham, instrumented uninjured shams
previously reported (15).
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Figure 4.

Lactate-pyruvate ratio (LPR) over time. (* P < 0.05 for overall group means). INJ, injured
animals without phenylephrine support; Sham, instrumented uninjured shams previously
reported (15).
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Figure 5.

Cerebral blood flow (CBF) over time. Two additional groups of animals were analyzed,
injured animals without CPP modulation (INJ, N=5) and instrumented shams (SHAM,
N=4). (*P < 0.05 at 6 hours post injury).
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Figure 6.

Traumatic axonal injury volumes determined by β-APP immunohistochemistry and cell
injury volumes determined by H&E at 6 hours post injury. (*P < 0.05).
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Table 1

Physiological Data
Physiological data pre-injury, 1 hour, 3 hours, and 6 hours post-injury.
Parameter

CPP 40

CPP 70

Baseline

108 ± 12

106 ± 10

1 hour

115 ± 11

100 ± 12

3 hour

120 ± 9

103 ± 13

6 hour

136 ± 12

136 ± 11

Baseline

69 ± 8

68 ± 9

1 hour

66 ± 12

73 ± 6

3 hour

70 ± 9

93 ± 5*

6 hour

62 ± 11

87 ± 4*

Baseline

36.4 ± 0.5

36.4 ± 0.5

1 hour

36.8 ± 0.4

36.8 ± 0.6

3 hour

37.2 ± 0.6

37.6 ± 0.6

6 hour

37.2 ± 0.6

37.6 ± 0.5

Heart Rate (beats/min)

MAP (mm Hg)

Temperature (°C)

(MAP) mean arterial pressure.

*

denotes statistically significant difference compared to CPP 40, P< 0.001 with Tukey-Kramer post-hoc analysis. ± standard deviation
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Table 2

Arterial Blood Gas Values
Arterial blood gas data pre-injury, 1 hour, 3 hours and 6 hours post-injury.
Parameter

CPP 40

CPP 70

Baseline

7.55 ± 0.03

7.54 ± 0.05

1 hour

7.51 ± 0.05

7.46 ± 0.05

3 hour

7.48 ± 0.05

7.49 ± 0.03

6 hour

7.51 ± 0.06

7.51 ± 0.03

Baseline

43.8 ± 2.1

44.8 ± 4.1

1 hour

46.1 ± 4.5

51.3 ± 2.4

3 hour

48.7 ± 3.1

47.1 ± 3.5

6 hour

45.2 ± 2.9

47.7 ± 3.3

Baseline

143.5 ± 17.1

140.1 ± 19.3

1 hour

138.1 ± 10.6

134.0 ± 15.1

3 hour

129.6 ± 12.3

134.2 ± 13.4

6 hour

132.5 ± 14.8

131.4 ± 15.2

Baseline

1.0 ± 0.3

1.0 ± 0.3

1 hour

1.6 ± 0.3

1.3 ± 0.2

3 hour

1.0 ± 0.2

0.9 ± 0.1

6 hour

1.2 ± 0.3

0.9 ± 0.2

Baseline

138.9 ± 4.1

141.1 ± 3.5

1 hour

138.5 ± 3.6

141.1 ± 3.9

3 hour

140.2 ± 3.4

139.7 ± 2.3

6 hour

137.6 ± 2.3

138.4 ± 2.5

Baseline

77 ± 6

82 ± 10

1 hour

120 ± 10

130 ± 16

3 hour

109 ± 12

116 ± 17

6 hour

82 ± 4

84 ± 5

pH

PaCO2 (torr)

PaO2 (torr)

Lactate (mmol/L)

Sodium (mmol/L)

Glucose (mg/dL)

± standard deviation.
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Table 3

Phenylephrine dosing and cerebral hemodynamics, 2, 4, and 6 hours post-injury.
Parameter

CPP 40

CPP 70

2 hour

0.5 ± 0.3

2.3 ± 1.5*

4 hour

0.6 ± 0.4

2.9 ± 1.3*

6 hour

0.5 ± 0.2

3.3 ± 0.9*

1 hour

20 ± 3

20 ± 4

2 hour

20 ± 4

19 ± 4

4 hour

20 ± 5

18 ± 4

6 hour

19 ± 4

18 ± 3

1 hour

44 ± 6

45 ± 6

2 hour

48 ± 4

75 ± 4*

4 hour

49 ± 5

79 ± 5*

6 hour

47 ± 4

71 ± 4*

Phenylephrine (mcg/kg/min)

ICP (mm Hg)

CPP (mm Hg)

(ICP) intracranial pressure, (CPP) cerebral perfusion pressure.

*

denotes statistically significant difference compared to CPP 40, P< 0.01 with Tukey-Kramer post-hoc analysis. ± standard deviation
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